These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9565587)

  • 1. Binding interaction of the heregulinbeta egf domain with ErbB3 and ErbB4 receptors assessed by alanine scanning mutagenesis.
    Jones JT; Ballinger MD; Pisacane PI; Lofgren JA; Fitzpatrick VD; Fairbrother WJ; Wells JA; Sliwkowski MX
    J Biol Chem; 1998 May; 273(19):11667-74. PubMed ID: 9565587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of heregulin variants having higher affinity for the ErbB3 receptor by monovalent phage display.
    Ballinger MD; Jones JT; Lofgren JA; Fairbrother WJ; Akita RW; Sliwkowski MX; Wells JA
    J Biol Chem; 1998 May; 273(19):11675-84. PubMed ID: 9565588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of a high affinity heregulin binding site using the soluble extracellular domains of ErbB2 with ErbB3 or ErbB4.
    Fitzpatrick VD; Pisacane PI; Vandlen RL; Sliwkowski MX
    FEBS Lett; 1998 Jul; 431(1):102-6. PubMed ID: 9684874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heregulin (HRG)-induced mitogenic signaling and cytotoxic activity of a HRG/PE40 ligand toxin in human breast cancer cells.
    Fiddes RJ; Janes PW; Sanderson GM; Sivertsen SP; Sutherland RL; Daly RJ
    Cell Growth Differ; 1995 Dec; 6(12):1567-77. PubMed ID: 9019162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structural basis for the specificity of epidermal growth factor and heregulin binding.
    Barbacci EG; Guarino BC; Stroh JG; Singleton DH; Rosnack KJ; Moyer JD; Andrews GC
    J Biol Chem; 1995 Apr; 270(16):9585-9. PubMed ID: 7721889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin regulates heregulin binding and ErbB3 expression in rat hepatocytes.
    Carver RS; Sliwkowski MX; Sitaric S; Russell WE
    J Biol Chem; 1996 Jun; 271(23):13491-6. PubMed ID: 8662847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of a Shc binding site tyrosine residue in ErbB3/HER3 blocks heregulin-dependent activation of mitogen-activated protein kinase.
    Vijapurkar U; Cheng K; Koland JG
    J Biol Chem; 1998 Aug; 273(33):20996-1002. PubMed ID: 9694850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.
    Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R
    Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The erbB3 gene product is a receptor for heregulin.
    Carraway KL; Sliwkowski MX; Akita R; Platko JV; Guy PM; Nuijens A; Diamonti AJ; Vandlen RL; Cantley LC; Cerione RA
    J Biol Chem; 1994 May; 269(19):14303-6. PubMed ID: 8188716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative constraints underlie the ErbB specificity of epidermal growth factor-like ligands.
    van der Woning SP; van Rotterdam W; Nabuurs SB; Venselaar H; Jacobs-Oomen S; Wingens M; Vriend G; Stortelers C; van Zoelen EJ
    J Biol Chem; 2006 Dec; 281(52):40033-40. PubMed ID: 17032651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A common requirement for the catalytic activity and both SH2 domains of SHP-2 in mitogen-activated protein (MAP) kinase activation by the ErbB family of receptors. A specific role for SHP-2 in map, but not c-Jun amino-terminal kinase activation.
    Deb TB; Wong L; Salomon DS; Zhou G; Dixon JE; Gutkind JS; Thompson SA; Johnson GR
    J Biol Chem; 1998 Jul; 273(27):16643-6. PubMed ID: 9642214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
    Feroz K; Williams E; Riese DJ
    Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
    Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH
    EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of beta1-integrin function by epidermal growth factor and heregulin-beta has distinct requirements for erbB2 but a similar dependence on phosphoinositide 3-OH kinase.
    Adelsman MA; McCarthy JB; Shimizu Y
    Mol Biol Cell; 1999 Sep; 10(9):2861-78. PubMed ID: 10473632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4.
    Lee H; Akita RW; Sliwkowski MX; Maihle NJ
    Cancer Res; 2001 Jun; 61(11):4467-73. PubMed ID: 11389077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF.
    Deb TB; Su L; Wong L; Bonvini E; Wells A; David M; Johnson GR
    J Biol Chem; 2001 May; 276(18):15554-60. PubMed ID: 11279155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replacement of N-terminal portions of TGF-alpha with corresponding heregulin sequences affects ligand-induced receptor signaling and intoxication of tumor cells by chimeric growth-factor toxins.
    Schmidt M; Wels W
    Int J Cancer; 2002 Jan; 97(3):349-56. PubMed ID: 11774287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness.
    Lewis GD; Lofgren JA; McMurtrey AE; Nuijens A; Fendly BM; Bauer KD; Sliwkowski MX
    Cancer Res; 1996 Mar; 56(6):1457-65. PubMed ID: 8640840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heregulin beta1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase.
    Tan M; Grijalva R; Yu D
    Cancer Res; 1999 Apr; 59(7):1620-5. PubMed ID: 10197638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transduction by epidermal growth factor and heregulin via the kinase-deficient ErbB3 protein.
    Kim HH; Vijapurkar U; Hellyer NJ; Bravo D; Koland JG
    Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):189-95. PubMed ID: 9693119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.